ERBB2 and neoplasm: Thus, these in vitro data suggest that the co-stimulatory molecule, CD80, which was expressed on CT26/HER2 cells, might play a role in producing higher IFN-γ levels by co-stimulating T cells, likely resulting in the suppression of CTL induction during tumor progression.